Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

131 ARTÍCULOS , VIENDO DEL 91 AL 105

Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort

Risacher SL, Shen L, West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2010 Aug;31(8):1401-18. doi: 10.1016/j.neurobiolaging.2010.04.029.

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

Zetzsche T, Rujescu D, Hardy J, Hampel H.

Expert Rev Mol Diagn. 2010 Jul;10(5):667-90. doi: 10.1586/erm.10.48.

[Alzheimer's disease: immunity and diagnosis]

Herrera-Rivero M, Hernández-Aguilar ME, Manzo J, Aranda-Abreu GE.

Rev Neurol. 2010 Aug;51(3):153-64.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Epub 2010 Jul 22.

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression

Colasanti T, Barbati C, Rosano G, Malorni W, Ortona E.

Autoimmun Rev. 2010 Oct;9(12):807-11. doi: 10.1016/j.autrev.2010.07.008. Epub 2010 Jul 23.

[Amyloid PET in Alzheimer research]

Ishii K.

Brain Nerve. 2010 Jul;62(7):757-67.

[Biological marker for Alzheimer's disease]

Matsubara E.

Brain Nerve. 2010 Jul;62(7):769-75.

Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings

Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, Pijnenburg YA, Lammertsma AA, Scheltens P, van Berckel BN.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):303-7. doi: 10.1097/WAD.0b013e3181cf35ec.

A meta-analysis of cytokines in Alzheimer's disease

Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N.

Biol Psychiatry. 2010 Nov 15;68(10):930-41. doi: 10.1016/j.biopsych.2010.06.012. Epub 2010 Aug 8.

Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation

Gu XM, Jiang ZF, Huang HC.

Chin J Integr Med. 2010 Jun;16(3):276-82. doi: 10.1007/s11655-010-0276-8. Epub 2010 Aug 8.

Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients

Stellos K, Panagiota V, Kögel A, Leyhe T, Gawaz M, Laske C.

J Cereb Blood Flow Metab. 2010 Nov;30(11):1817-20. doi: 10.1038/jcbfm.2010.140. Epub 2010 Aug 18.

Diagnostic biomarker for early stage of Alzheimer's disease: current state and view in the future

Urakami K.

Psychogeriatrics. 2010 Jun;10(2):49-52. doi: 10.1111/j.1479-8301.2010.00331.x.

Beyond the dawning of the age of biomarkers

Blacker D.

Am J Geriatr Psychiatry. 2010 Nov;18(11):955-8. doi: 10.1097/JGP.0b013e3181f52877.

BACE: Therapeutic target and potential biomarker for Alzheimer's disease

Evin G, Barakat A, Masters CL.

Int J Biochem Cell Biol. 2010 Dec;42(12):1923-6. doi: 10.1016/j.biocel.2010.08.017. Epub 2010 Sep 15.

Biomarkers of Alzheimer's disease and exercise: one step closer to prevention

Yaffe K.

Ann Neurol. 2010 Sep;68(3):275-6. doi: 10.1002/ana.22143.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias